The latest brain, head and neck cancer news
Helping cancer patients avoid excessive radiation
A Case Western Reserve University-led team of scientists in the USA has used Artificial Intelligence…
Browsing: Neuro-oncology, Head and Neck Cancers
Genetics and availability of treatments influence the management of head and neck cancer in Asia
The Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines was presented at the ESMO Asia…
New model reveals achieving an 80% HPV vaccination rate could eliminate nearly 1 million cases of male oropharyngeal cancer this century
A nationwide effort to adequately vaccinate 8 in 10 adolescents against the human papillomavirus (HPV)…
Genetic changes in neuroblastoma leading to tumour evolution
Tumours are heterogeneous, which means that different parts of the same tumour can be genetically…
Which glioblastoma patients will respond to immunotherapy?
Northwestern Medicine (USA) scientists have discovered a new biomarker to identify which patients with glioblastomas…
Saliva testing may allow early detection of human papillomavirus–driven head and neck cancers
Cancer causing high-risk human papillomaviruses (HR-HPV) are responsible for the rising incidence of HR-HPV–driven head…
ESMO 2021: CheckMate 651 study
Highlights on nivolumab plus ipilimumab vs EXTREME in 1st-line high-risk squamous cell carcinoma of the…
Immunotherapy for HPV positive head and neck cancer: Awakening the force within
A new study from scientists at Emory Vaccine Center and Winship Cancer Institute of Emory…
HPV vaccination will reduce throat and mouth cancers, but will take 25-plus years to see
Vaccinations against human papillomavirus (HPV), a major cause of throat and back of mouth cancers,…
Targeting brain cancer at its root
McGill University (USA) researchers identify proteins that drive cancer stem cells. Targeting and suppressing a…